IRIS
BACCARANI, Umberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 23.348
AS - Asia 9.953
EU - Europa 6.911
SA - Sud America 1.807
AF - Africa 250
Continente sconosciuto - Info sul continente non disponibili 23
OC - Oceania 10
Totale 42.302
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 22.993
SG - Singapore 4.770
CN - Cina 2.036
UA - Ucraina 1.682
DE - Germania 1.444
BR - Brasile 1.367
IT - Italia 1.019
HK - Hong Kong 940
VN - Vietnam 700
FI - Finlandia 626
RU - Federazione Russa 575
FR - Francia 437
IE - Irlanda 326
IN - India 305
TR - Turchia 256
GB - Regno Unito 238
BD - Bangladesh 215
SE - Svezia 193
CA - Canada 180
AR - Argentina 165
KR - Corea 139
MX - Messico 93
IQ - Iraq 87
EC - Ecuador 70
ID - Indonesia 68
ZA - Sudafrica 64
IR - Iran 56
NL - Olanda 56
PL - Polonia 55
VE - Venezuela 55
CO - Colombia 53
JP - Giappone 53
PK - Pakistan 53
ES - Italia 47
SA - Arabia Saudita 39
AT - Austria 35
BE - Belgio 34
PH - Filippine 34
CZ - Repubblica Ceca 32
EG - Egitto 29
KE - Kenya 29
MA - Marocco 29
PY - Paraguay 29
UZ - Uzbekistan 27
CL - Cile 25
AE - Emirati Arabi Uniti 21
PE - Perù 21
EU - Europa 20
TN - Tunisia 19
DZ - Algeria 18
JO - Giordania 16
TW - Taiwan 16
AZ - Azerbaigian 15
LT - Lituania 14
MY - Malesia 14
UY - Uruguay 14
CH - Svizzera 13
DO - Repubblica Dominicana 13
GR - Grecia 12
CR - Costa Rica 11
IL - Israele 11
PA - Panama 11
TG - Togo 11
JM - Giamaica 10
AL - Albania 9
ET - Etiopia 9
NP - Nepal 9
TT - Trinidad e Tobago 9
BG - Bulgaria 8
KZ - Kazakistan 8
MD - Moldavia 8
AU - Australia 7
OM - Oman 7
PS - Palestinian Territory 7
GE - Georgia 6
HR - Croazia 6
KG - Kirghizistan 6
LB - Libano 6
LV - Lettonia 6
AM - Armenia 5
BH - Bahrain 5
BO - Bolivia 5
CI - Costa d'Avorio 5
GT - Guatemala 5
HN - Honduras 5
LA - Repubblica Popolare Democratica del Laos 5
NG - Nigeria 5
NO - Norvegia 5
RO - Romania 5
TH - Thailandia 5
AO - Angola 4
HU - Ungheria 4
PR - Porto Rico 4
RW - Ruanda 4
SN - Senegal 4
BA - Bosnia-Erzegovina 3
BS - Bahamas 3
CY - Cipro 3
EE - Estonia 3
GP - Guadalupe 3
Totale 42.239
Salva come PNG Salva come JPEG
Città #
Fairfield 2.736
Ashburn 2.006
Woodbridge 1.815
Singapore 1.787
Houston 1.324
Jacksonville 1.172
Chandler 1.137
Wilmington 1.087
Seattle 1.054
Cambridge 978
Beijing 957
Hong Kong 936
Ann Arbor 924
San Jose 813
Dearborn 760
Udine 487
Boardman 428
Los Angeles 364
Lauterbourg 331
Princeton 330
Dublin 325
Council Bluffs 307
Dallas 267
Ho Chi Minh City 241
Hefei 172
Izmir 171
Buffalo 163
San Diego 151
São Paulo 140
Hanoi 138
New York 137
Chicago 132
Seoul 127
Munich 121
Redondo Beach 111
The Dalles 107
Santa Clara 87
Helsinki 86
Ogden 76
Mumbai 73
Des Moines 70
Ottawa 70
Dong Ket 69
Salt Lake City 64
Milan 63
Frankfurt am Main 59
Norwalk 56
Orem 56
Nanjing 50
Brooklyn 48
Kunming 47
Tokyo 46
Denver 41
Rio de Janeiro 41
Warsaw 40
Chennai 37
Phoenix 37
Washington 37
Guangzhou 36
London 36
Poplar 35
Toronto 34
Düsseldorf 33
Montreal 33
Baghdad 32
Brussels 32
Rome 32
Haiphong 31
Augusta 29
Da Nang 29
Porto Alegre 29
Turku 29
Brasília 28
Elk Grove Village 28
Tampa 28
Nuremberg 27
Quito 27
Boston 26
Johannesburg 26
Mexico City 25
Nairobi 25
Pittsburgh 25
Redmond 25
Ankara 24
Atlanta 24
Hyderabad 24
Stockholm 24
Belo Horizonte 23
Jinan 23
Manchester 23
Pune 23
Tashkent 23
Leawood 22
Trieste 22
Nanchang 21
Dhaka 20
San Francisco 20
Shanghai 20
Grafing 19
Lahore 19
Totale 26.603
Salva come PNG Salva come JPEG
Nome #
Appendiceal Mucinous Neoplasm (AMN); A Case Series and Literature Review 363
TFEB, SIRT1, CARM1, Beclin-1 expression and PITX2 methylation in breast cancer chemoresistance: a retrospective study 346
Extended Ureteral Stricture Corrected with Appendiceal Replacement in a Kidney Transplant Recipient 287
Which Type of Incision for Liver Transplantation? 256
In vitro functional assessment of a porcine hepatocytes based bioartificial liver 249
ROLE OF CYTOMEGALOVIRUS AND EPSTEIN-BARR VIRUS IN PATIENTS WITH DE NOVO COLON CANCER AFTER RENAL TRANSPLANTATION. 243
Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV recipients. 239
A single-center experience of late retransplantation of the liver. 234
Steatosis of the graft is a risk factor for posttransplantation biliary complications. 230
Ileocecal Fistula Caused by Multiple Foreign Magnetic Bodies Ingestion 211
Detection of transplant renal artery stenosis with contrast-enhanced ultrasound 209
LONG-TERM OUTCOMES OF ORTHOTOPIC LIVER TRANSPLANTATION IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS AND COMPARISON WITH HUMAN IMMUNODEFICIENCY VIRUS-NEGATIVE CASES 204
Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: Evidence from the Liver Match cohort study 202
Improved survival in liver transplant recipients receiving prolonged-release tacrolimus in the European liver transplant registry 198
Development of Small Bowel Volvulus on Barbed V-Loc™ Suture: A Rare Complication after Laparoscopic Ventral Rectopexy 198
A Matched Pair Analysis of Multicenter Long-term Follow-up after Split Liver Transplantation with Extended Right Grafts 197
Pharmacokinetic drug interaction between everolimus and antifungal triazoles in a liver transplant patient 195
A comparative prospective study of two available solutions for kidney and liver preservation 194
Differential proteomic analysis of hepatocellular carcinoma 194
Liver transplantation from old donors into HCV and non-HCV recipients 193
THE ROLE OF CYP3A5 GENOTYPE AND TACROLIMUS MONITORING IN STABLE KIDNEY TRANSPLANTATIONS 192
Cryopreserved human hepatocytes from cell bank: In vitro function and clinical application 184
. Quantification of human livers as an effective source of hepatocytes for clinical application 183
Isolation of Human Hepatocytes from Livers Rejected for Liver Transplantation on a National Basis: Results of a 2 Year-Experience 182
Single-time kidney transplantation and monolateral nephrectomy for hypertension and antihypertensive therapy in renal transplant recipients 182
Laparoscopic treatment of symptomatic lymphoceles after kidney transplantation 181
Antiretroviral blood levels in HIV/HCV-coinfected patients with cirrhosis after liver transplant: A report of three cases 181
Portal vein thrombosis after intraportal hepatocytes transplantation in a liver transplant recipient 180
Arterial rupture as the result of fungal arteritis after renal transplantation 175
DE NOVO TUMORS ARE A MAJOR CAUSE OF LATE MORTALITY AFTER ORTHOTOPIC LIVER TRANSPLANTATION 175
Complete Remission of Unresectable Hepatocellular Carcinoma after Combined Sorafenib and Adjuvant Yttrium-90 Radioembolization 175
Laparoscopic sleeve gastrectomy as a weight reduction strategy in obese patients after kidney transplantation 174
Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching 173
Impact of surgical complications on the risk of hepatocellular carcinoma recurrence after hepatic resection 173
Different miRNA expression in transplanted livers of HCV mono-infected and HCV/HIV co-infected recipients 172
Impact of new treatment options for hepatitis c virus infection in liver transplantation 172
Overoxidation of peroxiredoxins as an immediate and sensitive marker of oxidative stress in HepG2 cells and its application to the redox effects induced by ischemia/reperfusion in human liver 171
COMBINED APPROACH FOR SPONTANEOUS RUPTURE OF HEPATOCELLULAR CARCINOMA 170
Acute pancreatitis after kidney transplantation. 169
La splenectomia laparotomica e laparoscopica 168
Quality-of-life assessment before and after liver transplantation. 168
STEATOSIS OF THE HEPATIC GRAFT AS A RISK FACTOR FOR POST-TRANSPLANT BILIARY COMPLICATIONS 167
Steatotic versus cirrhotic livers as a source for human hepatocyte isolation 167
Fifteen years and 382 extended right grafts from in situ split livers in a multicenter study: Are these still extended criteria liver grafts? 167
RENAL ALLOGRAFT PROTECTION WITH EARLY ANGIOTENSIN-CONVERTING ENZYME INHIBITORS ADMINISTRATION 167
Hyperlactacidemia Potentially Due to Linezolid Overexposure in a Liver Transplant Recipient 166
APURINIC APYRIMIDINIC ENDONUCLEASE/REDOX EFFECTOR FACTOR 1 IMMUNOREACTIVITY AND GRADING IN HEPATOCELLULAR CARCINOMA RISK OF RELAPSE AFTER LIVER TRANSPLANTATION 166
Splenic Artery Syndrome as a Possible Cause of Late Onset Refractory Ascites after Liver Transplantation: Management with Proximal Splenic Artery Embolization 165
Hepatocyte isolation using human livers discarded from transplantation: Analysis of cell yield and function 164
A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list. 164
Diaphragm rupture in a liver transplant patient under chronic immunosuppressive therapy with sirolimus: rare complication after liver transplantation 162
Safety of conversion from twice-daily tacrolimus (Prograf) to once-daily prolonged-release tacrolimus (Advagraf) in stable liver transplant recipients 162
Donor safety in living donor liver donation: An Italian multicenter survey 160
Safety and efficacy of splenic artery embolization for portal hyperperfusion in liver transplant recipients: A 5-year experience 159
Transesophageal echocardiography in orthotopic liver transplantation: a comprehensive intraoperative monitoring tool 158
Treatment of Candida Infections with Fluconazole in Adult Liver Transplant Recipients: Is TDM-guided Dosing Adaptation Helpful? 158
Angiotensin-converting enzyme inhibitors reduce hemoglobin concentrations, hematocrit, and serum erythropoietin levels in renal transplant recipients without posttransplant erythrocytosis 157
Comparison of clinical and pathological staging and long-term results of liver transplantation for hepatocellular carcinoma in a single transplant center 157
Future of minimally invasive surgery 157
Graft vessel wall pathology in a case of hepatic artery pseudo-aneurysm in a liver transplant recipient 157
Postsplenectomy recurrence of idiopathic thrombocitopenic purpura: role of laparoscopic splenectomy in the treatment of accessory spleen 157
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. 156
CARDIOVASCULAR RISK FACTORS AND IMMUNOSUPPRESSIVE REGIMEN AFTER LIVER TRANSPLANTATION 156
MeltDose Technology vs Once-Daily Prolonged Release Tacrolimus in De Novo Liver Transplant Recipients 156
DE NOVO GASTROINTESTINAL TUMOURS AFTER RENAL TRANSPLANTATION: ROLE OF CMV AND EBV VIRUSES 155
Liver Retransplantation in Patients with HIV-1 Infection: An International Multicenter Cohort Study 155
OCCULT HEPATITIS B VIRUS INFECTION IN LIVER TRANSPLANT RECIPIENTS WITH RECURRENT HEPATITIS C: RELATIONSHIP WITH DONOR AGE AND FIBROSIS PROGRESSION 154
Biliary pharmacodynamic exposure to linezolid in two liver transplant patients. 153
Appendicectomy and Crohn's disease: clinical and genetic associations 152
Biliary penetration and pharmacodynamic exposure of linezolid in liver transplant patients 151
Differential Proteomic Analysis of Subfractioned Human Hepatocellular Carcinoma Tissues 151
De Novo Solid Tumors after Kidney Transplantation: Is It Time for a Patient-Tailored Risk Assessment? Experience from a Single Center 150
Sequential versus contemporaneous portal and arterial reperfusion during liver transplantation. 150
Split and whole liver transplantation outcomes: A comparative cohort study 149
De novo malignancies after kidney and liver transplantations: experience on 582 consecutive cases. 149
ELDERLY VERSUS YOUNG LIVER TRANSPLANT RECIPIENTS: PATIENT AND GRAFT SURVIVAL. 149
BENEFIT OF LAPAROSCOPY FOR RECTAL RESECTION IN PATIENTS OPERATED SIMULTANEOUSLY FOR SYNCHRONOUS LIVER METASTASES: PRELIMINARY EXPERIENCE. 149
Transarterial chemoembolization does not harm the hepatic artery at transplantation 149
Risk of virus and non-virus related malignancies following immunosuppression in a cohort of liver transplant recipients. Italy, 1985–2014 148
Vitamin D and the risk of acute allograft rejection following human liver transplantation. 147
Predictors of endoscopic treatment outcome in the management of biliary complications after orthotopic liver transplantation 146
A Simple Trick for Optimizing the Three-Vein Technique Outflow Anastomosis in Piggyback Liver Transplantation 144
Liberase HI enzyme versus collagenase type P for porcine hepatocyte isolation 144
RENAL TRANSPLANTATION IN A PATIENT AFFECTED BY MOUNIER-KUHN SYNDROME 144
Right lobe living related graft loss due to intrahepatic multiple arterio-portal fistulas. 144
DIAGNOSTIC, THERAPEUTIC AND EDUCATIONAL ASPECTS OF LAPAROSCOPIC CHOLANGIOGRAPHY 143
Application of a clinical score for the diagnosis of acute appendicitis in childhood: a retrospective analysis of 197 patients 143
GRAFT VESSEL WALL PATHOLOGY IN A CASE OF HEPATIC ARTERY PSEUDO-ANEURYSM IN A LIVER TRANSPLANT RECIPIENT. 143
Current preventive strategies and management of Epstein-Barr virus-related post-transplant lymphoproliferative disease in solid organ transplantation in Europe. Results of the ESGICH Questionnaire-based Cross-sectional Survey 143
Pharmacokinetic Profile of Prolonged-Release Tacrolimus When Administered via Nasogastric Tube in De Novo Liver Transplantation: A Sub-Study of the DIAMOND Trial 143
Intra-abdominal penetration and pharmacodynamic exposure to fluconazole in three liver transplant patients with deep-seated candidiasis 143
HIV-INFECTED PATIENTS AND LIVER TRANSPLANTATION: WHO, WHEN AND WHY 142
Intraoperative cholangiography in laparoscopic cholecystectomy during residency in general surgery 141
IMMUNESUPPRESSION AND CANCER: A COMPARISON OF RISKS IN RECIPIENTS OF ORGAN TRANSPLANTS AND HIV-POSITIVE INDIVIDUALS 141
Successful minimally invasive management of late portal vein thrombosis after splenectomy due to splenic artery steal syndrome following liver transplantation: a case report 140
Cardiovascular and metabolic complications after liver transplantation: Neoral- versus tacrolimus-based immunosuppression 139
Role of tumor associated fibroblasts in human liver regeneration, cirrhosis, and cancer. 139
TREATMENT OF RECURRENT SYMPTOMATIC LYMPHOCELE AFTER KIDNEY TRANSPLANTATION WITH INTRAPERITONEAL TENCKHOFF CATHETER 139
Non-erosive and uncomplicated erosive reflux diseases: Difference in physiopathological and symptom pattern. 139
Gastrointestinal Perforations in Adult Whole-Liver Transplant Patients: Clinical, Radiologic, and Histopathologic Analysis 139
Totale 17.297
Salva come PNG Salva come JPEG
Categoria #
all - tutte 163.066
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 163.066
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.537 109 280 73 128 36 97 168 139 34 472 604 397
2022/20232.588 358 212 41 335 233 701 6 170 337 30 70 95
2023/2024957 115 89 43 26 162 152 12 81 138 55 18 66
2024/20256.305 140 402 202 236 264 304 355 310 611 545 1.170 1.766
2025/202612.114 861 1.719 1.093 1.185 1.697 928 1.237 402 872 944 716 460
2026/2027239 239 0 0 0 0 0 0 0 0 0 0 0
Totale 42.846